Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Cited by (587)

Items 101–200 of 587

  1. Mechanisms of NLRP3 priming in inflammaging and age related diseases
    Anna Gritsenko, Jack Green, David Brough, Gloria López‐Castejón · 2020 · Cytokine & Growth Factor Reviews
  2. NLRP3 inflammasome in neurodegenerative disease
    Faith L. Anderson, Karl E. Biggs, Brynn E. Rankin, Matthew C. Havrda · 2022 · Translational research
  3. Mitochondria as a centrally positioned hub in the innate immune response
    Sandhir, Rajat, Halder, Avishek, Sunkaria, Aditya · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  4. Current Trends in Neurodegeneration: Cross Talks between Oxidative Stress, Cell Death, and Inflammation
    Tapan Behl, Rashita Makkar, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Gökhan Zengin, SIMONA GABRIELA BUNGAU, Felicia Liana Andronie-Cioară, Mihai Alexandru Munteanu, Mihaela Cristina Brisc et al. · 2021 · International Journal of Molecular Sciences
  5. Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
    Dorit Trudler, Kristopher L. Nazor, Yvonne S. Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan, Zhenyu Zhong, Marshall S. Goodwin, Yona Levites et al. · 2021 · Proceedings of the National Academy of Sciences
  6. Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study
    Koustav Chatterjee, Akash Roy, Rebecca Banerjee, Supriyo Choudhury, Banashree Mondal, Saptak Halder, Purba Basu, Shantanu Shubham, Sanjit Dey, Hrishikesh Kumar · 2019 · Journal of Neuroimmunology
  7. Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
    Isabella Russo, Giulia Berti, Nicoletta Plotegher, Greta Bernardo, Roberta Filograna, Luigi Bubacco, Elisa Greggio · 2015 · Journal of Neuroinflammation
  8. The Interplay between Intracellular Iron Homeostasis and Neuroinflammation in Neurodegenerative Diseases
    Jaewang Lee, Dong‐Hoon Hyun · 2023 · Antioxidants
  9. α‐Synuclein evokes NLRP3 inflammasome‐mediated IL ‐1β secretion from primary human microglia
    Adrianne F. Pike, Tatiana Varanita, Maaike A. C. Herrebout, Bonnie C. Plug, Jeroen Kole, René J.P. Musters, Charlotte Elisabeth Teunissen, Jeroen J.M. Hoozemans, Luigi Bubacco, Robert Veerhuis · 2021 · Glia
  10. IL-1 family cytokines in inflammation and immunity
    Cecília Garlanda, Irene Di Ceglie, Sébastien Jaillon · 2025 · Cellular and Molecular Immunology
  11. Protein Corona Mediated Uptake and Cytotoxicity of Silver Nanoparticles in Mouse Embryonic Fibroblast
    Marianna Barbalinardo, Federico Caicci, Massimiliano Cavallini, Denis Gentili · 2018 · Small
  12. Principles of inflammasome priming and inhibition: implications for psychiatric disorders
    Herman, Francis J., Pasinetti, Giulio Maria · 2018 · Brain, Behavior, and Immunity
  13. Microglial NLRP3 Inflammasome Activation Upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies
    Scheiblich, Hannah, Bousset, Luc, Schwartz, Stephanie, Griep, Angelika, Latz, Eicke, Melki, Ronald, Heneka, Michael T · 2021 · The Journal of Immunology
  14. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
    Adrianne F. Pike, Francesca Longhena, Gaia Faustini, Jean-Marc van Eik, Iris Gombert, Maaike A. C. Herrebout, Mona M.H.E Fayed, Michele Sandre, Tatiana Varanita, Charlotte Elisabeth Teunissen et al. · 2022 · Journal of Neuroinflammation
  15. Role of Microglia in Autism: Recent Advances
    Tomoyuki Takano · 2015 · Developmental Neuroscience
  16. Estrogen Attenuates Local Inflammasome Expression and Activation after Spinal Cord Injury
    A. Zendedel, Fabian Mönnink, G. Hassanzadeh, Arash Zaminy, M. Ansar, P. Habib, A. Slowik, M. Kipp, C. Beyer · 2017 · Molecular Neurobiology
  17. Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
    Streubel-Gallasch, Linn, Giusti, Veronica, Sandre, Michele, Tessari, Isabella, Plotegher, Nicoletta, Giusto, Elena, Masato, Anna, Iovino, Ludovica, Battisti, Ilaria, Arrigoni, Giorgio et al. · 2021 · Molecular Neurobiology
  18. Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
    Amanda N. Sacino, Mieu Brooks, Michael A. Thomas, Alex B. McKinney, Nicholas H. McGarvey, Nicola J. Rutherford, Carolina Ceballos‐Diaz, Janice Robertson, Todd Eliot Golde, Benoit I. Giasson · 2014 · Acta Neuropathologica
  19. SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
    Gaber El‐Saber Batiha, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Engy Elekhnawy · 2022 · Inflammopharmacology
  20. Cell Death and Neurodegeneration
    Benjamin J. Andreone, Martin Larhammar, Joseph W. Lewcock · 2019 · Cold Spring Harbor Perspectives in Biology
  21. Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease
    Souvarish Sarkar, Hai Minh Nguyen, Emir Malovic, Jie Denny Luo, Monica Renee Langley, Bharathi N. Palanisamy, Neeraj Singh, Sireesha Manne, Matthew P Neal, Michelle Gabrielle et al. · 2020 · Journal of Clinical Investigation
  22. NLRP inflammasomes in health and disease
    Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Yin Zhou, Tengchuan Jin · 2024 · Molecular Biomedicine
  23. Microglia and inflammation: conspiracy, controversy or control?
    Fernandes, Adelaide, Miller-Fleming, Leonor, Pais, Teresa F. · 2014 · Cellular and Molecular Life Sciences
  24. Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
    Giuseppe Arena, Karan Sharma, Gideon Agyeah, Rejko Krüger, Anne Grünewald, Julia Catherine Fitzgerald · 2022 · Current Neurology and Neuroscience Reports
  25. A novel role of NLRP3-generated IL-1β in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: implications for sepsis-associated neurodegeneration
    Zhao, Zhan, Wang, Yubao, Zhou, Ran, Li, Yi, Gao, Yun, Tu, Dezhen, Wilson, Belinda, Song, Sheng, Feng, Jing, Hong, Jau-Shyong et al. · 2020 · Journal of Neuroinflammation
  26. TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
    Gorecki, Anastazja M., Anyaegbu, Chidozie C., Anderton, Ryan S. · 2021 · Translational Neurodegeneration
  27. Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
    Mariza Bortolanza, Glauce Crivelaro Nascimento, Sergio B. Socías, Diego Ploper, Rosana Nieves Chehín, Rita Raisman‐Vozari, Elaine Aparecida Del Bel · 2018 · Journal of Neural Transmission
  28. Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
    Noha A. Gouda, Ahmed Elkamhawy, Jungsook Cho · 2022 · Biomedicines
  29. Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate
    Gregory Hook, J. Steven Jacobsen, Kenneth H. Grabstein, Mark S. Kindy, VIVIAN Y. H. HOOK · 2015 · Frontiers in Neurology
  30. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases
    Carolina Pellegrini, Matteo Fornai, Luca Antonioli, Corrado Blandizzi, Vincenzo Calderone · 2019 · International Journal of Molecular Sciences
  31. Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease
    Ruwani Wijeyekoon, Deborah Kronenberg‐Versteeg, Kirsten M. Scott, Shaista Hayat, Wei‐Li Kuan, Jonathan Evans, David P. Breen, Gemma A. Cummins, Joanne Jones, Menna Ruth Clatworthy et al. · 2020 · Brain Behavior and Immunity
  32. Inflammasomes in neurological disorders — mechanisms and therapeutic potential
    Kishore Aravind Ravichandran, Michael Thomas Heneka · 2024 · Nature Reviews Neurology
  33. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Ali Keshavarzian, Phillip A. Engen, Salvatore Bonvegna, Roberto Cilia · 2020 · Progress in brain research
  34. C-Reactive Protein and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis
    Xiaohui Qiu, Yousheng Xiao, Jingjing Wu, Lu Gan, Yanning Huang, Jin Wang · 2019 · Frontiers in Neurology
  35. Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis
    Yuling Liu, Chia‐Chi Hsu, Hui-Ju Huang, Chih‐Jung Chang, Shu-Hui Sun, Anya Maan‐Yuh Lin · 2019 · Molecular Neurobiology
  36. Correction to: Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
    Craig D. Hughes, Minee L. Choi, Mina Ryten, Lee Hopkins, Anna Drews, Juan Antonio Botía, Maria Iljina, Margarida Rodrigues, Sarah A. Gagliano Taliun, Sonia Gandhi et al. · 2018 · Acta Neuropathologica
  37. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
    Qiu-Qin Han, Weidong Le · 2023 · Neuroscience Bulletin
  38. PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
    François Mouton‐Liger, Maxime Jacoupy, Jean‐Christophe Corvol, Olga Corti · 2017 · Frontiers in Molecular Neuroscience
  39. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice
    Yongchul Jang, Jung‐Hoon Koo, Insu Kwon, Eun‐Bum Kang, Hyun-Seob Um, Hideaki Soya, Youngil Lee, Joon‐Yong Cho · 2016 · Brain Research
  40. Neuroinflammation in Sepsis: Molecular Pathways of Microglia Activation
    Carolina A. Moraes, Camila Zaverucha-do-Valle, Renaud Fleurance, Tarek Sharshar, Fernando A. Bozza, Joana C. d’Avila · 2021 · Pharmaceuticals
  41. The role of Galectin-3 in ¿-synuclein-induced microglial activation
    Antonio Boza‐Serrano, Juan F. Reyes, Nolwen L. Rey, Hakon Leffler, Luc Bousset, Ulf J. Nilsson, Patrik Brundin, Jose Luis Venero, Miguel Ángel Burguillos, Tomas Deierborg · 2014 · Acta Neuropathologica Communications
  42. Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells
    Souvarish Sarkar, Eric B. Dammer, Emir Malovic, Abby L. Olsen, Syed Ali Raza, Tianwen Gao, Hailian Xiao, Danielle L. Oliver, Duc Minh Duong, Valerie L. Joers et al. · 2020 · Frontiers in Immunology
  43. Bibliometric Analysis of the Inflammasome and Pyroptosis in Brain
    Yuhua Chen, Yan Li, Limin Guo, Jun Young Hong, Wenjuan Zhao, Ximin Hu, Cuicui Chang, Wei Liu, Kun Xiong · 2021 · Frontiers in Pharmacology
  44. The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways
    Danlu Jiang, Sheng Chen, Ruyu Sun, Xue Zhang, Di Wang · 2018 · Cancer Letters
  45. Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
    David Harrison, Andy Billinton, Mark G. Bock, John R. Doedens, Christopher A. Gabel, M. Katharine Holloway, Roderick A. Porter, Valérie Reader, Jane Scanlon, Kenneth Schooley et al. · 2023 · Journal of Medicinal Chemistry
  46. NLRP3 Inflammasome Activation Mediates Zika Virus–Associated Inflammation
    Zhenjian He, Jiahui Chen, Xun Zhu, Shu An, Xinhuai Dong, Jianchen Yu, Shihao Zhang, Yun Wu, Ge Li, Yu Long Zhang et al. · 2018 · The Journal of Infectious Diseases
  47. Iron Toxicity in the Retina Requires Alu RNA and the NLRP3 Inflammasome
    Bradley D. Gelfand, Charles B. Wright, Younghee Kim, Tetsuhiro R. Yasuma, Reo Yasuma, Shengjian Li, Benjamin J. Fowler, Ana Bastos-Carvalho, Nagaraj Kerur, Annette Uittenbogaard et al. · 2015 · Cell Reports
  48. Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
    Madiha Rasheed, Junhan Liang, Chaolei Wang, Yulin Deng, Zixuan Chen · 2021 · International Journal of Molecular Sciences
  49. Alterations in Blood Monocyte Functions in Parkinson's Disease
    Sara Konstantin Nissen, Kalpana Shrivastava, Claudia Schulte, Daniel E. Otzen, David Goldeck, Daniela Berg, Holger Jon Møller, Walter Maetzler, Marina Romero‐Ramos · 2019 · Movement Disorders
  50. Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
    Qian-Qian Chen, Caroline Haikal, Wen Li, Jiayi Li · 2019 · Frontiers in Molecular Neuroscience
  51. The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
    Maria Sebastian-Valverde, Giulio Maria Pasinetti · 2020 · Cells
  52. Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
    Yadi Guan, Fang Han · 2020 · Frontiers in Integrative Neuroscience
  53. Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
    Linh Thi Nhat Nguyen, Hữu Đạt Nguyễn, Yun Joong Kim, Tinh Thi Nguyen, Thuy Thi Lai, Yoon Kyoung Lee, Hyeo‐Il Ma, Young Eun Kim · 2022 · Journal of Parkinson s Disease
  54. Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis
    Mattia Cocco, Davide Garella, Antonella Di Stilo, Emily Borretto, Livio Stevanato, Marta Giorgis, Elisabetta Marini, Roberto Fantozzi, Gianluca Miglio, Massimo Bertinaria · 2014 · Journal of Medicinal Chemistry
  55. Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective
    Shuanglong Yi, Linfang Wang, Honglei Wang, Margaret Su-chun Ho, Shiping Zhang · 2022 · International Journal of Molecular Sciences
  56. NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
    Mohammed Alrouji, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Athanasios T. Alexiou, Marios Papadakis, Majid Sakhi Jabir, Hebatallah M. Saad, Gaber El‐Saber Batiha · 2023 · Journal of Cellular and Molecular Medicine
  57. Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
    Amanda N. Sacino, Mieu Brooks, Nicholas H. McGarvey, Alex B. McKinney, Michael A Thomas, Yona Levites, Yong Ran, Todd Eliot Golde, Benoit I. Giasson · 2013 · Acta Neuropathologica Communications
  58. Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
    Bora Tastan, Burak Ibrahim Arioz, Şermin Genç · 2022 · Frontiers in Immunology
  59. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain
    Francesca L’Episcopo, Cataldo Tirolo, Maria Francesca Serapide, Salvatore Caniglia, Nunzio Testa, Loredana Leggio, Silvia Vivarelli, Nunzio Iraci, Stefano Pluchino, Bianca Marchetti · 2018 · Frontiers in Aging Neuroscience
  60. Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation
    Ce Chen, Yi-Zheng Wei, Xuemei He, Daidi Li, Guoqing Wang, Jing-Jie Li, Feng Zhang · 2019 · Frontiers in Immunology
  61. Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
    Faith L. Anderson, Katharine M. von Herrmann, Angeline S. Andrew, Yuliya I. Kuras, Alison L. Young, Clemens R. Scherzer, William F. Hickey, Stephen Lee, Matthew C. Havrda · 2021 · npj Parkinson s Disease
  62. Impact of monomeric, oligomeric and fibrillar alpha-synuclein on astrocyte reactivity and toxicity to neurons
    Cecilia Chavarría, Sebastián Rodríguez-Bottero, Celia Quijano, Patricia Cassina, José M. Souza · 2018 · Biochemical Journal
  63. MicroRNAs as important regulators of the NLRP3 inflammasome
    Parvin Zamani, Reza Kazemi Oskuee, Stephen Lawrence Atkin, Jamshid Gholizadeh Navashenaq, Amirhossein Sahebkar · 2019 · Progress in Biophysics and Molecular Biology
  64. Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review
    Yue Lang, Fengna Chu, Donghui Shen, Weiguanliu Zhang, Chao Zheng, Jie Zhu, Li Cui · 2018 · Mediators of Inflammation
  65. Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
    Kasen, Alysa, Houck, Christina, Burmeister, Amanda R., Sha, Qiong, Brundin, Lena, Brundin, Patrik · 2022 · Neurobiology of Disease
  66. Endoplasmic reticulum stress, an important factor in the development of Parkinson’s disease
    Zheng Mou, Yu‐He Yuan, Zhao Zhang, Lian-Kun Song, Nai‐Hong Chen · 2020 · Toxicology Letters
  67. Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
    Yueran Cui, Haiyang Yu, Zhongqi Bu, Lulu Wen, Li-Li Yan, Juan Feng · 2022 · Frontiers in Molecular Neuroscience
  68. Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice
    Machado, Venissa, Zöller, Tanja, Attaai, Abdelraheim, Spittau, Björn · 2016 · International Journal of Molecular Sciences
  69. Pharmacology of apocynin: a natural acetophenone
    Shreya R. Savla, Ankit Pravin Laddha, Yogesh Anant Kulkarni · 2021 · Drug Metabolism Reviews
  70. NLRP3 inflammasome as a sensor of micro- and nanoplastics immunotoxicity
    Andi Alijagić, Alexander Hedbrant, Alexander Persson, Maria Larsson, Magnus Engwall, Eva Särndahl · 2023 · Frontiers in Immunology
  71. Inflammasomes: Mechanisms of Action and Involvement in Human Diseases
    Dimitri Bulté, Chiara Rigamonti, Alessandro Romano, Alessandra Mortellaro · 2023 · Cells
  72. Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
    Tereza Filipi, Zuzana Heřmanová, Jana Turečková, Ondřej Vaňátko, Miroslava Anděrová · 2020 · Journal of Clinical Medicine
  73. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease
    Nataša Z. Kuštrimović, Franca Marino, Marco Cosentino · 2018 · Current Medicinal Chemistry
  74. Alpha-synuclein fibrils recruit TBK1 and OPTN to lysosomal damage sites and induce autophagy in microglial cells
    Claudio Bussi, Javier María Peralta Ramos, Daniela Soledad Arroyo, José Ignacio Gallea, Paolo Ronchi, Androniki Kolovou, Ji M. Wang, Oliver Florey, M. Soledad Celej, Yannick Schwab et al. · 2018 · Journal of Cell Science
  75. Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages
    Eunju Lee, Jun-Cheol Eo, Changjun Lee, Je‐Wook Yu · 2021 · Molecules and Cells
  76. Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
    Virna Margarita Martín Giménez, Natalia de las Heras, Vicente Lahera, Jesús A.F. Tresguerres, Russel Joseph Reiter, Walter A. Manucha · 2022 · Frontiers in Aging Neuroscience
  77. Targeting Inflammasomes to Treat Neurological Diseases
    Jan D. Lünemann, Sunny Malhotra, Mari L. Shinohara, Xavier Montalbán, Manuel Comabella · 2021 · Annals of Neurology
  78. Pyroptosis in development, inflammation and disease
    Yuhong Pan, Wenjun Cai, Juan Huang, Anchun Cheng, Mingshu Wang, Zhongqiong Yin, Renyong Jia · 2022 · Frontiers in Immunology
  79. The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
    Elena Possemato, Livia La Barbera, Annalisa Nobili, Paraskevi Krashia, Marcello D’Amelio · 2023 · Ageing Research Reviews
  80. The impact of neuroinflammation on neuronal integrity
    Bora Tastan, Michael Thomas Heneka · 2024 · Immunological Reviews
  81. A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington’s disease
    Kai-Po Chen, Kuo‐Feng Hua, Fu-Ting Tsai, Ting-Yu Lin, Chih‐Yuan Cheng, Ding‐I Yang, Hsien-Ta Hsu, Tz‐Chuen Ju · 2022 · Journal of Neuroinflammation
  82. ER-mitochondria communication is involved in NLRP3 inflammasome activation under stress conditions in the innate immune system
    Ana Catarina Pereira, Jessica De Pascale, Rosa Resende, Susana Cardoso, Isabel Ferreira, Bruno Miguel Neves, Mylène A. Carrascal, Mónica Zuzarte, Nuno Gonçalo Gomes Fernandes Madeira, Sofia Morais et al. · 2022 · Cellular and Molecular Life Sciences
  83. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease
    Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, Arjunan Karuppaiah, Divakar Selvaraj · 2022 · Neurochemistry International
  84. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes
    Taraneh Ebrahimi, Marcus Immanuel Rust, Sarah Kaiser, Alexander Slowik, Cordian Beyer, Andreas Rembert Koczulla, Jörg Bernhard Schulz, Pardes Habib, Jan‐Philipp Bach · 2018 · Journal of Neuroinflammation
  85. NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
    Yiqun Yan, Yi Fang, Ran Zheng, Jiali Pu, Baorong Zhang · 2020 · Neuroscience
  86. Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
    Pasquale Pagliaro, Claudia Renata Rezende Penna · 2023 · Antioxidants
  87. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
    Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek‐Kamińska, Ireneusz Majsterek · 2023 · International Journal of Molecular Sciences
  88. The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation‐mediated metabolic diseases
    Sisay Teka Degechisa, Yosef Tsegaye Dabi, Solomon Tebeje Gizaw · 2022 · Immunity Inflammation and Disease
  89. Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
    Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Yaser Hosny Ali Elewa, Mahmoud Hosny Zahran, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2023 · Cellular and Molecular Neurobiology
  90. Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
    Marie‐Thérèse Armentero, Silvia Cerri, Fabio Blandini · 2019 · Frontiers in Neurology
  91. Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases
    Nina Boxberger, Michael Hecker, Uwe Klaus Zettl · 2019 · The Journal of Immunology
  92. Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
    Roberta Mancuso, Simone Agostini, Ambra Hernis, Milena Zanzottera, Anna Bianchi, Mario Clerici · 2019 · Scientific Reports
  93. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson’s disease by regulating the TLR2/MyD88/NF-κB signaling pathway
    Jung‐Hoon Koo, Yongchul Jang, Dong-Ju Hwang, Hyun-Seob Um, Namhee Lee, Jae-Hoon Jung, Joon‐Yong Cho · 2017 · Neuroscience
  94. Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease
    Xinglong Yang, Kelu Li, Hongyan Huang, Hui Ren · 2022 · Neural Regeneration Research
  95. microRNAs in Neurodegeneration: Current Findings and Potential Impacts
    Salil Sharma, Hui‐Chen Lu · 2018 · Journal of Alzheimer’s Disease & Parkinsonism
  96. Underlying Mechanism of Lysosomal Membrane Permeabilization in CNS Injury: A Literature Review
    Linyi Xiang, Junsheng Lou, Jiayi Zhao, Yibo Geng, Jiacheng Zhang, Yuzhe Wu, Yinuo Zhao, Zhichao Tao, Li Yao, Jianjun Qi et al. · 2024 · Molecular Neurobiology
  97. Mulberroside a protects against ischemic impairment in primary culture of rat cortical neurons after oxygen-glucose deprivation followed by reperfusion
    Caiping Wang, Lu‐Zhong Zhang, Guicai Li, Yunwei Shi, Jianlong Li, Xiaochuan Zhang, Zhi-Wei Wang, Fei Ding, Xinmiao Liang · 2014 · Journal of Neuroscience Research
  98. Asiatic Acid Protects Dopaminergic Neurons from Neuroinflammation by Suppressing Mitochondrial ROS Production
    Dong Chen, Xiaoya Zhang, Jing Sun, Qijie Cong, Wei-Xiong Chen, Hafiz Muhammad Ahsan, Jing Gao, Jin-Jun Qian · 2019 · Biomolecules & Therapeutics
  99. Update of inflammasome activation in microglia/macrophage in aging and aging‐related disease
    Mengyan Hu, Yinyao Lin, Bingjun Zhang, Danli Lu, Zhengqi Lu, Wei Cai · 2019 · CNS Neuroscience & Therapeutics
  100. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro‐inflammatory phenotype
    Juan Xiong, Tammy Kielian · 2013 · Journal of Neurochemistry